-
Associations between the meniscal lesion parameters and knee joint structures and symptoms in patients with symptomatic knee osteoarthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-06-03
Kaida Bo, Xin Liu, Yuanyi Zhang, Jianliang Ou, Xu Wang, Maolin Yang, Lianhui Zhao, Zhangwei Wu, Jingfeng Liu, Shuo Yang, Wei Zhang, Lelei Zhang, Zhonglin Xu, Kun Cao, Jun ChangTo investigate cross-sectional associations between meniscal lesion parameters and knee joint structures and symptoms in patients with symptomatic knee osteoarthritis (KOA). A total of 102 subjects with symptomatic KOA were included in this study. Coronal magnetic resonance imaging was used to measure the meniscal parameters including the mean distance from medial to lateral meniscal lesions (Mean(MLD))
-
Artificial intelligence-based Raynaud’s quantification index (ARTIX): an objective mobile-based tool for patient-centered assessment of Raynaud’s phenomenon Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-06-03
Marco Di Battista, Seda Colak, Anna Howard, Francesca Donadoni, Chris Owen-Smith, Andrea Rindone, Stefano Di Donato, Collette Hartley, Lesley-Anne Bissell, Francesco Del GaldoWe aimed to develop an artificial intelligence algorithm able to assess Raynaud’s phenomenon (RP) from mobile phone photography, ensuring as a patient-centered, image-based method for RP quantification. ARTIX (artificial intelligence-based Raynaud’s quantification index) score was developed as a multi-step process of segmentation, decomposition and filters application to mobile phone pictures of the
-
Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-06-02
Adéla Navrátilová, Sabína Oreská, Hana Wünsch, Klára Mocová, Ondřej Kodet, Marian Rybar, Glenda Alquicer, Aneta Prokopcová, Viktor Bečvář, Radim Bečvář, Aneta Jiránková, Anna Bobrová, Kateřina Bobrová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Lucie Andrés Cerezo, Michal TomčíkInterleukin 40 (IL-40) is a cytokine implicated in malignancies and rheumatic disorders. Its association with fibrotic mediators has been previously described. Since inflammation and fibrosis are hallmarks of systemic sclerosis (SSc), we aimed to analyze the role of IL-40 in SSc. IL-40 levels were analyzed in the serum of 90 SSc patients and 75 healthy controls (HCs). IL-40 expression in dermal biopsies
-
Roles of VWA1 and Rac2 in compensatory and decompensatory responses via FGF9/FGFR3 and p38 MAPK signaling pathways in condylar chondrocytes under distinct mechanical stress Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-31
Yuqi Liu, Fangwen Jia, Kangya Li, Chao Liang, Yanxi Li, Wei GengFew studies paid attention to compensatory and decompensatory responses of condylar cartilage under different mechanical conditions and the underlying mechanism. Compensatory and decompensatory models were established. In vivo compensatory (0.5 mm occlusal elevation) and decompensatory (1.5 mm elevation) models were established in rats using zirconia occlusal plates. Parallel in vitro models subjected
-
Osteoclast development from peripheral blood monocytes is reduced in patients with radiographic axial spondyloarthritis on biological therapy Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-30
Cecilia Engdahl, Malin C. Erlandsson, Magnus Hallström, Anna Deminger, Helena Forsblad-d’EliaRadiographic axial spondyloarthritis (r-axSpA) is a chronic inflammatory disease that primarily affects the axial skeleton and entheses, leading to pathological spinal bone formation and systemic bone loss. Treatments with tumor necrosis factor inhibitors (TNFi) and interleukin-17 inhibitors (IL-17i) have shown efficacy in reducing inflammation and potentially impacting bone remodeling in r-axSpA.
-
Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-29
Kanako Kojima, Kunihiro Ichinose, Masataka Umeda, Toshimasa Shimizu, Shuntaro Sato, Takahisa Suzuki, Yoshikazu Nakashima, Akitomo Okada, Yoshiro Horai, Keita Fujikawa, Toshiyuki Aramaki, Taiichiro Miyashita, Masako Furuyama, Naoki Matsuoka, Atsushi KawakamiThe human monoclonal antibody belimumab (BEL) has emerged as a promising treatment for systemic lupus erythematosus (SLE), particularly for reducing the need for glucocorticoids and minimizing organ damage. The optimal timing of BEL initiation has been unclear; emerging evidence suggests that early intervention with BEL, particularly within the first 5 years of diagnosis, may yield better outcomes
-
Clinical features, treatment, and outcome of isotretinoin-associated sacroiliitis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-26
Shaoli Zhao, Wei Sun, Liping Peng, Chunjiang WangSacroiliitis is a rare adverse reaction of isotretinoin. However, the data on the clinical features, treatment and outcomes of isotretinoin-associated sacroiliitis are limited. This study was conducted to explore the clinical characteristics of isotretinoin-associated sacroiliitis, providing a basis for diagnosis and treatment. The author retrieved clinical reports of isotretinoin-associated sacroiliitis
-
Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-26
Behdin Nowrouzi-Kia, Aaron S. Howe, Anson Li, Jeremy Tan, Natalia Saade-Cleves, Kevon Jules, Malak Sadek, Ali Bani-Fatemi, Antonio Avina-Zubieta, Mary T. Fox, William Shaw, Derek Haaland, Janet Pope, Paul R. Fortin, Kathleen S. Bingham, Christine Peschken, Jennifer Reynolds, Catherine Ivory, Dafna D. Gladman, Murray B. Urowitz, Jorge Sanchez-Guerrero, Lily S. H. Lim, Stephanie Keeling, Patti Katz,Systemic lupus erythematosus (SLE) disease symptoms that can significantly restrict work ability and work participation resulting in reduced mental well-being. This study investigates the significant impact of work participation and disability on the mental wellbeing, health-related quality of life, and disease-related outcomes in individuals with SLE. With the objective of creating an SLE-related
-
Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-26
Jae-Bum Jun, Hye-Soon Lee, Sang-Hyon Kim, Seung-Geun Lee, Doo-Ho Lim, Jinhyun Kim, Yong-Beom Park, Mie Jin Lim, Seung-Jae Hong, Hyo-Jin Choi, Shin-Seok Lee, Hyun Ah Kim, Jiwon Hwang, Chang-Hee Suh, Seungwoo Han, Jung-Yoon Choe, Wan-Hee Yoo, Jung Soo SongGout is the most common inflammatory arthritis. Current urate-lowering therapies have limitations, such as adverse drug reactions or limited efficacy. Epaminurad is a novel selective human urate transporter 1 (hURAT1) inhibitor that has been shown to reduce serum urate (sUA) levels in healthy volunteers and patients with gout. The aims of the current study were to evaluate the urate-lowering efficacy
-
Physical activity in relation to health status, quality of life and compliance with World Health Organization recommendations in patients with axial spondyloarthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-21
M. Carbo, B. Hilberdink, D. Paap, F. Wink, T. Vliet Vlieland, S. van Weely, A. Spoorenberg, S. ArendsPhysical activity (PA) has well-established benefits and is a fundamental component in the management of axial spondyloarthritis (axSpA). Our objective was to evaluate (1) compliance with the World Health Organization (WHO) PA recommendations, (2) specific types and duration of PA performed by patients, and (3) association of PA with health status and quality of life (QoL) in two large Dutch cohorts
-
Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-21
Zihan Wang, Tianyi Lan, Yi Jiao, Xing Wang, Hongwei Yu, Qishun Geng, Jiahe Xu, Cheng Xiao, Qingwen Tao, Yuan XuTo develop a predictive model for bone destruction in patients with rheumatoid arthritis (RA), based on the characteristics of plasma metabolites and common clinical indicators. The cohort comprised 60 patients with RA, with baseline metabolite features identified using the liquid chromatograph-mass spectrometer system. Radiographic outcomes were assessed using the van der Heijde-modified total Sharp
-
Clinicopathological profile of eosinophilic fasciitis: a retrospective cohort study from a neuromuscular disorder center in China Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-19
Xiaoyuan Wang, Lining Zhang, Ying Hou, Tingjun Dai, Xiaotian Ma, Kai Shao, Chuanzhu Yan, Bing ZhaoTo characterize the clinical and myo-fascial histopathological features, along with long-term treatment outcomes of patients with eosinophilic fasciitis (EF). We performed a retrospective analysis of the clinical, serological, myo-fascial pathological features, as well as the long-term follow-up outcomes of EF patients between January 2011 and August 2023 at our neuromuscular disorder (NMD) center
-
Beyond symptomatic alignment: evaluating the integration of causal mechanisms in matching animal models with human pathotypes in osteoarthritis research Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-17
Eva Reihs, Anita Fischer, Iris Gerner, Reinhard Windhager, Stefan Toegel, Frank Zaucke, Mario Rothbauer, Florien JennerOsteoarthritis (OA) is a highly prevalent and disabling condition lacking curative treatments, with only symptomatic relief available. Recognizing OA as a heterogenous disorder with diverse aetiologies and molecular foundations underscores the need to classify patients by both phenotypes and molecular pathomechanisms (endotypes). Such stratification could enable the development of targeted therapies
-
Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-17
Jeffrey R. Curtis, Danielle M. Conrad, Whitney S. Krueger, Andrew P. Gara, Kevin L. WinthropRisk of cardiovascular events may increase after herpes zoster; therefore, American College of Rheumatology guidelines strongly recommend vaccination against herpes zoster in patients aged ≥ 18 years with rheumatic and musculoskeletal diseases taking immunosuppressive medications. Here, we investigated the effectiveness of Shingrix among patients with inflammatory arthritis and estimated the post-herpes
-
Endotheliopathy in systemic sclerosis: from endothelium-dependent vasodilation to the dysfunction of the vascular reserve, is the paradise lost? Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-17
Giulia Bandini, Silvia Bellando Randone, Mirko Manetti, Lorenzo Dagna, Marco Matucci Cerinic, Alberto Moggi PignoneMicrovascular dysfunction is considered one of the main pathogenetic pathways in systemic sclerosis (SSc), and endothelial cells plays a pivotal role even in the early phases of the disease. Endothelial dysfunction results in an early incapacity to adapt the vascular tone and the blood flow under stress conditions, thus losing the important adaptation mechanism that is the vascular reserve. The loss
-
Vagotomy and the incidence of rheumatoid arthritis and osteoarthritis: a Danish register-based study Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-16
Matthew C. Baker, Dávid Nagy, Suzanne Tamang, Erzsébet Horváth-Puhó, Henrik Toft SørensenGiven the potential role of vagus nerve stimulation in treating rheumatoid arthritis (RA), we examined the incidence of RA and osteoarthritis (OA) in patients who underwent different forms of vagotomy that disparately affect the inflammatory reflex. Using nationwide health registries, we constructed cohorts of patients in Denmark who underwent truncal or superselective vagotomy between 1977 and 1995
-
Atf3 + senescent chondrocytes mediate meniscus degeneration in aging Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-15
Jing-Yi Wang, Yao-Hui Liu, Xiao Wang, Min Ma, Zhang-Yi Pan, Ao-Yuan Fan, Lai-Ya Lu, Zheng Liu, Kun Tao, Feng YinMeniscus degeneration contributes to knee arthritis progression, but the cellular and molecular mechanisms of meniscus aging remain poorly understood. We aimed to characterize age-related changes in the rat meniscus using single-cell RNA sequencing (scRNA-seq) and identify key pathogenic cell populations and pathways. Meniscal tissues from young (12 weeks) and aged (24 months) rats were processed for
-
Chondrocyte lysates activate NLRP3 inflammasome-induced pyroptosis in synovial fibroblasts to exacerbate knee synovitis by downregulating caveolin-1 Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-15
Xue Du, Ruonan Liu, Zongrui Jiang, Chengyun Zhang, Zhijian Yang, Shu Hu, Zhiqi ZhangSynovitis, among the most common signs of early-stage osteoarthritis (OA), is mainly mediated by fibroblast-like synoviocytes (FLSs). Cartilage destruction creates chondrocyte lysates (CLs) that activate synovial inflammation. A comprehensive understanding of chondrocyte–FLS communication might offer novel, specific therapeutic targets for treating synovitis and OA. Hence, we sought to uncover the
-
Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-14
Paloma Vela-Casasempere, Lucía Otero-Varela, Silvia Gómez Sabater, Rocío Caño Alameda, Cristina Campos Fernández, Jerusalén Calvo-Gutiérrez, Yanira Pérez-Vera, Sara Manrique Arija, Sagrario Bustabad, Javier Manero Ruiz, María Dolores Ruiz Montesino, Lucía Ruíz Gutiérrez, Antonio Mera Varela, Manuel José Moreno Ramos, Fernando Sánchez-Alonso, Isabel CastrejónRheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease that can lead to progressive joint damage and irreversible disability when inadequately treated. RA is more common in women than in men. Disease characteristics differ between genders in terms of comorbidities, extra-articular manifestations, quality of life, disease activity and functional scores. There is a possibility
-
CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future? Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-10
Maurine Jouret, Sebastien Viel, Benjamin Fournier, Sarah Benezech, Jérome Avouac, Marc Scherlinger, Alexandre BelotChimeric antigen receptor (CAR) T-cell therapy targeting B cells has shown promising results, including drug-free remission, in adult-onset autoimmune diseases. Extending this therapeutic approach to the pediatric population, particularly for juvenile autoimmune diseases, presents an exciting opportunity. However, challenges specific to juvenile-onset autoimmune conditions, such as long-term adverse
-
Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies – comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-08
Tineke J. van Wesemael, Fraser R. Morton, Judith W. Heutz, Marc P. Maurits, Annemarie L. Dorjée, Duncan Porter, Tom W. J. Huizinga, Karim Raza, Rene E. M. Toes, Rachel Knevel, Pascal H. P. de Jong, Anna Svärd, Diane van der WoudeRheumatoid arthritis (RA) is an autoimmune disease characterized by the presence of autoantibodies against modified proteins, known as anti-modified protein autoantibodies (AMPAs). While the relationship between different AMPA isotypes and various risk factors remains poorly understood, investigating this association is important for a deeper understanding of RA pathophysiology. Smoking, has its primary
-
Recent advances in omics and the integration of multi-omics in osteoarthritis research Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-05-03
Ye Liu, Vladimir Molchanov, David Brass, Tao YangOsteoarthritis (OA) is a complex disorder driven by the combination of environmental and genetic factors. Given its high global prevalence and heterogeneity, developing effective and personalized treatment methods is crucial. This requires identifying new disease mechanisms, drug targets, and biomarkers. Various omics approaches have been applied to identify OA-related genes, pathways, and biomarkers
-
Resistin upregulates fatty acid oxidation in synoviocytes of metabolic syndrome-associated knee osteoarthritis via CAP1/PKA/CREB to promote inflammation and catabolism Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-29
Lu Ding, Jin-Yi Ren, Yi-Fan Huang, Jian-Zeng Zhang, Zi-Ran Bai, Yi Leng, Jun-Wei Tian, Jing Wei, Min-Li Jin, Guan Wang, Xia Li, Xin QiMetabolic Syndrome (MetS), as a syndrome characterized by low-grade inflammation and energy metabolism disorders, is considered to be an important systemic risk factor for knee osteoarthritis (KOA). Our previous study showed that the protein level of serum resistin was positively correlated with the degree of metabolic disorder in MetS-OA. However, whether Resistin promotes the progression of KOA synovitis
-
Comprehensive comparative analysis of infrapatellar fat pad morphologies in a longitudinal knee osteoarthritis exploratory study: new insights into its role as an independent prognostic marker Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-26
Jean-Pierre Pelletier, Patrice Paiement, François Abram, Marc Dorais, Jean-Pierre Raynauld, Johanne Martel-PelletierNo established markers can effectively phenotype knee osteoarthritis (OA) patients into subgroups. Infrapatellar fat pad (IPFP) morphology data that can forecast disease symptoms, structural changes, and knee replacement (KR) are sparse and conflicting. This 96-month longitudinal exploratory study aimed to identify which IPFP morphological features were the most effective independent prognostic markers
-
circ_0002970 promotes fibroblast-like synoviocytes invasion and the inflammatory response through Hippo/YAP signaling to induce CTGF/CCN1 expression in rheumatoid arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-25
Haoran Kong, Yushuang Qiao, Dahu Qi, Shixin Zhao, Zhiming Cao, Junhao Feng, Yitong Li, Yunke Liu, Tao LiuRheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovial inflammation, hyperplasia, and joint destruction. Fibroblast-like synoviocytes (FLSs) are key effector cells in RA, contributing to synovial invasion, extracellular matrix degradation, and inflammatory cytokine secretion. Recent studies suggest that circular RNAs (circRNAs) regulate cellular function and disease progression
-
Bioinformatic analysis and experimental verification reveal expansion of monocyte subsets with an interferon signature in systemic lupus erythematosus patients Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-25
Jimin Zhang, Wuwei Zhuang, Yan Li, Chaoqiong Deng, Jingxiu Xuan, Yuechi Sun, Yan HeSystemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by chronic inflammation and multi-organ damage. A central factor in SLE pathogenesis is the excessive production of type I interferon (IFN-I), which drives immune dysregulation. Monocytes, key components of the immune system, significantly contribute to IFN-I production. However, their specific roles in SLE remain incompletely
-
Exhausted natural killer cells in adult IgA vasculitis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-23
Matija Bajželj, Emanuela Senjor, Nika Boštic, Matjaž Hladnik, Snežna Sodin-Šemrl, Milica Perišić Nanut, Janko Kos, Alojz Ihan, Alojzija Hočevar, Andreja Nataša Kopitar, Katja LakotaIgA vasculitis nephritis (IgAVN) manifests in up to 84% of adult patients with IgA vasculitis (IgAV) and is associated with an elevated risk of progression to chronic kidney failure. The underlying pathogenic mechanism of adult IgAVN in leukocytes remain largely uncharacterised. Although natural killer (NK) cells were investigated in paediatric IgAV, their specific role in the pathogenesis of adult
-
Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-23
Aoife M. O’Byrne, Janne W. Bolt, Chaja M.J. van Ansenwoude, Martijn van der Heijde, Johanna F. Semmelink, Aldo Jongejan, Perry D. Moerland, Mario Maas, Marleen G.H. van de Sande, Lisa G.M. van BaarsenLymph node (LN) studies in anti-cyclic citrullinated protein antibodies (ACPA) positive rheumatoid arthritis (RA) patients have revealed notable alterations in adaptive immune cell populations. However, it remains unclear whether similar changes occur in seronegative inflammatory arthritis, such as psoriatic arthritis (PsA) or ACPA-negative RA. This study investigates molecular and cellular alterations
-
Regional brain function study in patients with primary Sjögren’s syndrome Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-23
Chunfeng Hu, Luoyu Wang, Jiao Huang, Yushan Shang, Xiaofang Zhang, Xinyun Du, Huijun Cao, Zhijiang Han, Peiying WeiPrimary Sjögren’s syndrome (pSS) manifests a spectrum of neuropsychological symptoms, primarily cognitive impairment, but the mechanism of central nervous system damage remains unclear. This study sought to analyze differences in the static and dynamic fractional amplitude of low-frequency fluctuation (fALFF) and region homogeneity (ReHo) between pSS patients and healthy controls (HCs), aiming to elucidate
-
Correction: efficacy of adipose stromal cells-enriched high-density fat graft combined with BTX-A for Raynaud’s phenomenon: a prospective cohort study Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-22
Chengliang Deng, Xin Liu, Miaomiao Wei, Bihua Wu, Tianhua Zhang, Shune Xiao, Peiru Min, Yixin ZhangCorrection: Arthritis Res Ther 27, 56 (2025) https://doi.org/10.1186/s13075-025-03533-8 Following publication of the original article [1], the authors noticed an error in Fig. 1. Specifically, the number of subjects in the control group was incorrectly labelled and should be changed to 9. Fig. 1 Flow chart of this prospective cohort studyFull size image Fig. 2 Flow chart of this prospective cohort
-
Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-17
Teppei Hashimoto, Kazuyuki Tsuboi, Takeo Abe, Takahiro Yoshikawa, Kazuteru Noguchi, Tetsuya Furukawa, Koji Tateishi, Yasuhiro Terashima, Nao Sibanuma, Naoto Azuma, Takashi Yamane, Kiyoshi Matsui, Akira HashiramotoInflammatory cytokine levels exhibit a circadian rhythm in sera, peaking from late night to early morning in patients with rheumatoid arthritis (RA). This cytokine kinetics is a recognized therapeutic target. This clinical study aimed to evaluate the effectiveness of night-time baricitinib administration based on cytokine secretion. In this 52-week multicenter non-randomized controlled study, 122 patients
-
Bulk RNA-seq conjoined with ScRNA-seq analysis reveals the molecular characteristics of nucleus pulposus cell ferroptosis in rat aging intervertebral discs Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-17
Shipeng Chen, Jiawei Fu, Jiang Long, Chang Liu, Xuezheng Ai, Dan Long, Xue Leng, Yang Zhang, Zhengao Liao, Changqing Li, Yue Zhou, Shiwu Dong, Bo Huang, Chencheng FengRecently, several studies have reported that nucleus pulposus (NP) cell ferroptosis plays a key role in IDD. However, the characteristics and molecular mechanisms of cell subsets involved remain unclear. We aimed to define the key factors driving ferroptosis, and the characteristics of ferroptotic NP cells subsets during IDD. The accumulation of iron ions in NP tissues of rats caudal intervertebral
-
Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-16
Aya Shimizu, Kazuhiro Kurasawa, Tomoka Hiyama, Sara Komatsu, Azusa Kikuchi, Yuhi Yoshida, Anna Hasegawa, Tomoyuki Miyao, Ayae Tanaka, Satoko Arai, Reika Maezawa, Masafumi Arima, Kei IkedaTo identify pathways linking cytokine abnormalities to mortality via prognostic factors in patients with anti-melanoma differentiation-associated protein 5 antibodies (anti-MDA5 Ab). This study included patients with anti-MDA5 Ab whose serum was available. Serum cytokine levels were measured using a multiplex bead assay. Prognostic factors were identified using Cox regression and log-rank test. Prognostic
-
Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort study Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-16
Wei-Sheng Chen, Hui-Ching Hsu, Tzu-Min Lin, Yu-Sheng Chang, Yi-Chun Lin, Tzu-Tung Kuo, Yu-Chuan Shen, Shu-Chuan Chen, Jin-Hua Chen, Hsiang-Yen Lee, Chi-Ching ChangHydroxychloroquine (HCQ) is commonly used to treat Sjögren syndrome (SS). Glucocorticoids, which are commonly applied for managing primary SS (pSS), can disrupt glucose metabolism and increase diabetes mellitus (DM) risk. HCQ reduces DM risk in systemic lupus erythematosus and rheumatoid arthritis. This study aimed to investigate the relationship between HCQ and glucocorticoids in the incidence of
-
Impact of Mediterranean diet on mortality in vertebral compression fracture patients Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-16
Longyu Zhang, Yi Zhao, Jiao Xu, Shi Yin, Qiang Wang, Zhiwei Jia, Jingpei Ren, Cong Zhao, Xiaohong MuVertebral compression fractures (VCF) is a common fragility fracture with high mortality worldwide. The management and prevention of VCF start with a proper nutrition. The Mediterranean diet (MD) is rich in balanced nutrients and has been shown to be beneficial for several chronic diseases. However, the association of adherence to Mediterranean diet (aMED) and prognosis of VCF patients remains unclear
-
The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-16
Juliette Marin, Penelope Bourgoin, Noemie Saverna, Celia Cartagena, Pierre Lafforgue, Jean-Marc Busnel, Nathalie BalandraudThe spike protein-specific humoral response observed after SARS-CoV- 2 vaccination is decreased in rheumatoid arthritis (RA) patients treated with rituximab (RTX). However, when analyzed immediately after vaccination, the spike-specific T-cell immune response appears to be preserved. The possible persistence of specific T cells over the long term is underexplored and could be a useful decision-making
-
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-11
Ilayda Gunes, Elana J. Bernstein, Shawn E. Cowper, Gauri Panse, Niki Pradhan, Lucy Duran Camacho, Nicolas Page, Elizabeth Bundschuh, Alyssa Williams, Mary Carns, Kathleen Aren, Sarah Fantus, Elizabeth R. Volkmann, Heather Bukiri, Chase Correia, Vijaya B. Kolachalama, F. Perry Wilson, Seamus Mawe, J. Matthew Mahoney, Monique HinchcliffThe modified Rodnan skin score (mRSS), a measure of systemic sclerosis (SSc) skin thickness, is agnostic to inflammation and vasculopathy. Previously, we demonstrated the potential of neural network-based digital pathology applied to SSc skin biopsies as a quantitative outcome. Here, we leverage deep learning and histologic analyses of clinical trial biopsies to decipher SSc skin features ‘seen’ by
-
Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-10
Andrew Östör, Eugen Feist, Prodromos Sidiropoulos, Jérôme Avouac, Martin Rebella, Rajaie Namas, Erin McDearmon-Blondell, Tianming Gao, Ivan Lagunes-Galindo, Sander Strengholt, Devy Zisman, Suzan AttarUpadacitinib (UPA), an oral Janus kinase inhibitor, has shown efficacy with an acceptable safety profile in rheumatoid arthritis (RA) clinical trials. To assess the real-world effectiveness and safety of UPA in adults with moderate-to-severe RA in the UPHOLD observational study. Co-primary endpoints were: (i) proportion of patients achieving disease activity score in 28 joints using C-reactive protein
-
CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-10
Weiwei Hao, Qianqian Liu, Xiaoping Li, Yiran Xu, Wenjuan Guan, Lei Zhang, Fang Dong, Wenjun Cao, Shengyun Liu, Wei LiThe present cohort study aimed to evaluate the value of CCL23 in diagnosis, disease activity, and prognosis in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). CCL23 levels in serum samples from 317 patients with AAV and 83 healthy controls (HCs) were measured using a customized immune response kit. Patients with AAV had significantly elevated CL23 levels compared with
-
Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-05
Shuji Asai, Toshihisa Kojima, Hajime Ishikawa, Nobumasa Miyake, Masanari Kodera, Hisanori Hasegawa, Yasumori Sobue, Yasuhide Kanayama, Hiromi Shimada, Yuji Hirano, Toshihiko Hidaka, Takayoshi Fujibayashi, Takuya Matsumoto, Tomonori Kobayakawa, Hidekata Yasuoka, Takefumi Kato, Masahiro Hanabayashi, Yuko Kaneko, Masahiro Tada, Koichi Murata, Kenta Misaki, Masahiko Ando, Yachiyo Kuwatsuka, Mochihito SuzukiThe present non-inferiority study was designed to compare the effect of discontinuing versus continuing methotrexate (MTX) alongside certolizumab pegol (CZP) on maintaining low disease activity (LDA) in rheumatoid arthritis (RA) patients already stable on combination therapy. This multicentre, open-label, randomised, controlled trial included RA patients with sustained LDA (Clinical Disease Activity
-
Infrapatellar fat pad as a source of biomarkers and therapeutic target for knee osteoarthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-05
Betzabeth Pereira Herrera, Kaj Emanuel, Pieter J. Emans, Martijn van Griensven, Berta Cillero-PastorOsteoarthritis (OA) is a multifactorial and highly prevalent disease in elderly adults; however, its pathogenesis, diagnosis, and treatment are unmet needs nowadays. Research efforts have focused on elucidating the molecular mechanisms involved in the pathogenesis, onset, and progression of OA to facilitate early detection and effective therapeutic approaches. Infrapatellar fat pad (IPFP) represents
-
Methotrexate-related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-05
Kai Khoroshun, Carsten Bantel, Falk Hoffmann, Kathrin JobskiMethotrexate (MTX), a standard treatment for rheumatoid arthritis (RA), is known for its potential kidney and liver toxicity. Whether concomitant use of analgesics, possibly affecting the same organs, has an impact on the occurrence or course of adverse drug reactions (ADRs) remains unclear. We used all spontaneous reports (until 2022) of suspected ADRs associated with MTX in RA patients, from the
-
Cluster analysis reveals three clinical phenotypes of pulmonary artery hypertension associated with connective tissue diseases: insights into inflammation and immunity Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-05
Qianwen Wu, Dongyu Li, Huangshu Ye, Zhangdi Zhou, Yixin Zhang, Miaojia Zhang, Xiaoxuan Sun, Qiang WangInflammation and immune mechanisms play a crucial role in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH), though they remain inadequately understood. This study aimed to identify specific clinical phenotypes in CTD-PAH using inflammatory and immune markers through hierarchical cluster analysis. We conducted a single-center, retrospective cohort study of CTD-PAH patients
-
Concomitant Sjögren’s disease in patients with NMOSD: impacts on neurologic disease severity and recurrence Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-05
Wanqing Wu, Wenbo Yang, Bo Deng, Helian Li, Xiaoni Liu, Hai Yu, Xiang Zhang, Minrui Liang, Xiangjun ChenWe aimed to characterize the phenotype of neuromyelitis optica spectrum disorder (NMOSD) in the presence and absence of Sjogren's disease (SjD) and to develop a predictive nomogram to evaluate the risk of coexisting SjD within a single tertiary-center cohort of NMOSD patients. Paraclinical and clinical features of patients with SjD were compared between NMOSD patients with SjD and those without SjD
-
25 years of research and therapy in arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-02
Harris Perlman, Christopher D. BuckleyWhen it was established 25 years ago by Peter Lipsky and Ravinder Maini, Rheumatology as a speciality, like Cinderella, had just arrived at the ball. Anti TNF therapy was revolutionizing the treatment of not just inflammatory arthritis, but many other immune mediated inflammatory diseases. For the first time people with arthritis could dream of a cure. But to cure a disease requires an understanding
-
Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathway Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-01
Ana Merino-Vico, Merve Kocyigit, Giulia Frazzei, Lisa Landman, Louis Boon, Ester M. van Leeuwen, Ingrid E. Lundberg, Anneke J. van der Kooi, Joost Raaphorst, Jan Piet van Hamburg, Sander W. TasIdiopathic inflammatory myopathies (IIM) are autoimmune disorders characterized by muscle inflammation and autoreactive B cell responses. The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway is essential for B cell functions, making it a promising therapeutic target. This study explores the potential of tofacitinib, a JAK1/JAK3 inhibitor, to modulate B cell
-
A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-01
Yubo Shao, Yazhu Yang, XiaoYu Yang, Zihang Xu, Hong Zhang, Ning Li, Hao Xu, Yongjian Zhao, Yongjun Wang, Qi Shi, Qianqian LiangThe risk of developing osteoporosis (OP) is increased in patients with rheumatoid arthritis (RA), which is associated with poorer prognosis and higher mortality. Many patients with RA may experience bone loss early in the disease course. Therefore, timely assessment of the risk of OP in RA patients is essential. This is a retrospective study in which we collected information from 500 RA patients who
-
Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-04-01
Elise F. Gray-Gaillard, Ami A. Shah, Clifton O. Bingham III, Jennifer H. Elisseeff, Joseph Murray, Julie Brahmer, Patrick Forde, Valsamo Anagnostou, Jennifer Mammen, Laura C. CappelliImmune checkpoint inhibitors (ICI), a type of cancer immunotherapy, can cause side effects including inflammatory arthritis (ICI-IA). Previous studies of ICI-IA do not include a thorough characterization of associated immune responses to provide potential targets for treatment. We aimed to identify cytokines uniquely increased in ICI-IA and determine correlations with IA severity and persistence. We
-
Editorial Expression of Concern: A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-31
Betti Giusti, Gabriella Fibbi, Francesca Margheri, Simona Serratì, Luciana Rossi, Filippo Poggi, Ilaria Lapini, Alberto Magi, Angela Del Rosso, Marina Cinelli, Serena Guiducci, Bashar Kahaleh, Laura Bazzichi, Stefano Bombardieri, Marco Matucci-Cerinic, Gian Franco Gensini, Mario Del Rosso, Rosanna AbbateEditorial Expression of Concern: Arthritis Res Ther 8, R115 (2006) https://doi.org/10.1186/ar2002 The Editors-in-Chief are issuing an editorial expression of concern to alert readers that panel C in Fig. 3 appears to be very similar to panel H in Fig. 2 in a previously-published article by the same author group [1], but the images are labelled differently. Due to the age of the articles, it is not
-
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-31
Marta Calatroni, Emanuele Conte, Matteo Stella, Federica De Liso, Francesco Reggiani, Gabriella MoroniKidney involvement is frequent in SLE, with proliferative lupus nephritis (LN) forms and nephritic flares being key predictors of poor outcomes. Conflicting results have been reported for anti-C1q antibodies among the serological markers. Our purpose was to assess the value of immunological tests (C3,C4 complement fractions, anti-DNA and antiC1q antibodies) in predicting histological classes and flares
-
Latent class analysis identifies distinct pain phenotypes in newly diagnosed systemic juvenile idiopathic arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-31
Hui Zhang, Xiaoqiong Wei, Wei Liu, Hongyao Leng, Qiao Shen, Xin Wan, Ximing Xu, Xianlan ZhengPatients with systemic juvenile idiopathic arthritis (sJIA) exhibit highly heterogeneous pain manifestations, which significantly impact their quality of life and disease prognosis. An understanding of the pain phenotypes for this disorder and their influencing factors is crucial for individualized pain management. To explore the pain phenotypes of newly diagnosed sJIA patients via latent class analysis
-
The insula represents a key neurobiological pain hub in psoriatic arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-31
Flavia Sunzini, Kristian Stefanov, Salim Al-Wasity, Chelsea Kaplan, Andrew Schrepf, Noah Waller, Steven Harte, Richard Harris, Daniel J. Clauw, John McLean, Stefan Siebert, Carl S. Goodyear, Gordon D. Waiter, Neil BasuPain remains a principal complaint for people with psoriatic arthritis (PsA), despite successful mitigation of inflammation. This situation alludes to the co-existence of distinct pain mechanisms. Nociceptive and nociplastic mechanisms are clinically challenging to distinguish. Advances in brain functional magnetic resonance imaging (fMRI) have successfully characterised distinct pain mechanisms across
-
Serum phospholipids and sphingolipids are linked to early-stage osteoarthritis by lipidomic profiling Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-31
Gerrit Eichner, Gerhard Liebisch, Christiane Hild, Markus Rickert, Juergen SteinmeyerOsteoarthritis (OA) is associated with abnormal lipid metabolism, wherein elevated levels of phospholipids (PLs) and sphingolipids (SLs) in human and canine synovial fluid (SF) have been observed. The aim of this lipidomic study was to evaluate how closely blood lipid levels reflect changes in SF, building on previous findings. Lipids were extracted from knee SF and serum of 44 joint-healthy donors
-
The TLR-M-CSF axis is implicated in increased bone turnover and curve progression in adolescent idiopathic scoliosis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-31
Kai Sheng, Daniel G. Bisson, Neil Saran, Jake Bourdages, Christopher Coluni, Kirby Upshaw, Kerstin Tiedemann, Svetlana V. Komarova, Jean A. Ouellet, Lisbet HaglundFacet joint osteoarthritis (OA) is prevalent in patients with adolescent idiopathic scoliosis (AIS). The most pronounced OA presents above and below the curve's apex where the intervertebral rotation is the greatest. This indicates that facet joint OA is implicated and potentially contributes to AIS progression. OA impacts both cartilage and bone and we have previously demonstrated an association between
-
Using in vivo calcium imaging to examine joint neuron spontaneous activity and home cage analysis to monitor activity changes in mouse models of arthritis Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-27
George L. Goodwin, Alina-Cristina Marin, Julia Vlachaki Walker, Carl Hobbs, Franziska DenkStudying pain in rodent models of arthritis is challenging. For example, assessing functional changes in joint neurons is challenging due to their relative scarcity amongst all sensory neurons. Additionally, studying pain behaviors in rodent models of arthritis poses its own set of difficulties. Commonly used tests, such as static weight-bearing, often require restraint, which can induce stress and
-
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-27
S. Bellando-Randone, H. Wilhalme, C. Bruni, L. Czirjak, O. Distler, Y. Allanore, G. Cuomo, C. Denton, F. Del Galdo, A. M. Gheorghiu, V. Riccieri, U. Walker, M. E. Truchetet, M. C. Vonk, I. Foeldvari, M. Matucci-Cerinic, D. E. FurstTo evaluate the use of hydroxychloroquine (HCQ) and its impact on the Health Assessment Questionnaire disability index(HAQ-DI) and the Cochin Hand Function Status(CHFS) in a large Systemic Sclerosis (SSc) cohort. SSc patients from the European Scleroderma Trials and Research (EUSTAR) database treated with HCQ for at least 6 months were evaluated and compared to a matched group of SSc patients not using
-
Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-26
Takayuki Fujii, Koichi Murata, Hirohiko Kohjitani, Akira Onishi, Kosaku Murakami, Masao Tanaka, Wataru Yamamoto, Koji Nagai, Ayaka Yoshikawa, Yuki Etani, Yasutaka Okita, Naofumi Yoshida, Hideki Amuro, Tadashi Okano, Yo Ueda, Takaichi Okano, Ryota Hara, Motomu Hashimoto, Akio Morinobu, Shuichi MatsudaUndifferentiated arthritis (UA) often develops into rheumatoid arthritis (RA), but predicting disease progression from seronegative UA remains challenging because seronegative RA often does not meet the classification criteria. This study aims to build a machine learning (ML) model to predict the progression from seronegative UA to RA using clinical and laboratory parameters. KURAMA cohort (training
-
Correction: IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-25
Xiaomei Yang, Qingwei Guo, Tingting Feng, Qiqi Lu, Luna Ge, Jihong Pan, Kehong Bi, Li Qiao, Lei Tian, Tianhua Xie, Chengfang Yao, Guanhua Song, Lin Wanghttps://doi.org/10.1186/s13075-020-02270-4. Following publication of the original article [1], the authors reported an error in Fig. 5D. The images of haematoxylin-eosin (H&E) and Safranin O/Fast green staining in Fig. 5d was mistakenly used, as more than one pathological gene, besides IL13Rα1 was investigated. The corrected Fig. 5D is provided below. Fig. 5 Incorrect FigureFull size image Fig. 5 Correct
-
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-21
Oliver Distler, Madelon C Vonk, Arata Azuma, Maureen D. Mayes, Dinesh Khanna, Kristin B. Highland, Gerrit Toenges, Margarida Alves, Yannick AllanoreWe used data from the SENSCIS and SENSCIS-ON trials to assess decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who received long-term treatment with nintedanib and the effect of switching patients from placebo to nintedanib. In the SENSCIS trial, patients were randomised to receive nintedanib or placebo until the last patient
-
Nailfold videocapillaroscopy findings are associated with IIM subtypes and IFN activation Arthritis Res. Ther. (IF 4.4) Pub Date : 2025-03-20
Mingwei Tang, Jia Shi, Yiyun Pang, Shuang Zhou, Jinjing Liu, Chanyuan Wu, Mengtao Li, Xiaofeng Zeng, Qian WangThis study aimed to characterize nailfold videocapillaroscopy (NVC) features in patients with different subtypes of Idiopathic inflammatory myopathy (IIM) and to investigate the correlations between NVC findings, myositis-specific antibody (MSA) subtypes, disease activity, cytokine profiles, and interferon-stimulated gene (ISG) expression levels. This cross-sectional observational single-center study